Clinical Trial

A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous Urticaria

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS-3095 with Chronic Spontaneous in adults, and to explore the reasonable dosage of HRS-3095 for Chronic Spontaneous Urticaria.
Trial Details
NCT Number NCT07613866
Lead Sponsor Chengdu Suncadia Medicine Co., Ltd.
Conditions Chronic Spontaneous Urticaria
Enrollment 190 participants
Start Date 2026-07
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-29